Validation of a novel diabetic retinopathy utility index using discrete choice experiments.

Eva Katie FenwickNick BansbackAlfred Tau Liang GanJulie RatcliffeLeonie BurgessTien Yin WongEcosse Luc Lamoureux

Published in: The British journal of ophthalmology (2019)

The DRU-I can estimate utilities associated with vision-threatening DR and associated vision impairment. It has the potential to assess the cost-effectiveness of DR interventions from a patient perspective and inform policies on resource allocation relating to DR.

Keyphrases

diabetic retinopathy
editorial comment
optical coherence tomography
public health
case report
risk assessment
climate change